Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reese W Randle

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
AJR. American Journal of Roentgenology|May 14, 2025
Incidentally Detected Parathyroid Glands on CT: Comparison of Size Thresholds for Defining Enlargement-A Secondary AnalysisKarol L Cardenas, Kevin D Hiatt, Joseph Rigdon, et al.
Journal of Patient Experience|February 7, 2024
Multidisciplinary Endocrine Tumor Board: Assessment of the Patient ExperienceMatthew A Gorris, McKenzie L Needham, Kayla C Finnegan, et al.
Annals of Surgical Oncology|August 29, 2013
Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascitesReese W Randle, Katrina R Swett, Douglas S Swords, et al.
Annals of Surgical Oncology|June 27, 2013
Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumorsKonstantinos I Votanopoulos, Douglas S Swords, Katrina R Swett, et al.
Surgery|November 13, 2017
Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease?Maria F Bates, Marcos R Lamas, Reese W Randle, et al.
Surgery|November 16, 2016
Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 yearsReese W Randle, Courtney J Balentine, Glen E Leverson, et al.
Annals of Surgical Oncology|November 13, 2013
Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Konstantinos I Votanopoulos, Reese W Randle, Brandon Craven, et al.
Journal of Surgical Oncology|January 6, 2015
Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapyReese W Randle, Shuja Ahmed, Edward A Levine, et al.
The Journal of Surgical Research|July 17, 2017
Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidismAndrew J Lowell, Norah M Bushman, Xing Wang, et al.
The Journal of Surgical Research|April 18, 2015
Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyReese W Randle, Kayla F Griffith, Nora F Fino, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
AJR. American Journal of Roentgenology|May 14, 2025
Incidentally Detected Parathyroid Glands on CT: Comparison of Size Thresholds for Defining Enlargement-A Secondary AnalysisKarol L Cardenas, Kevin D Hiatt, Joseph Rigdon, et al.
Journal of Patient Experience|February 7, 2024
Multidisciplinary Endocrine Tumor Board: Assessment of the Patient ExperienceMatthew A Gorris, McKenzie L Needham, Kayla C Finnegan, et al.
Annals of Surgical Oncology|August 29, 2013
Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascitesReese W Randle, Katrina R Swett, Douglas S Swords, et al.
Annals of Surgical Oncology|June 27, 2013
Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumorsKonstantinos I Votanopoulos, Douglas S Swords, Katrina R Swett, et al.
Surgery|November 13, 2017
Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease?Maria F Bates, Marcos R Lamas, Reese W Randle, et al.
Surgery|November 16, 2016
Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 yearsReese W Randle, Courtney J Balentine, Glen E Leverson, et al.
Annals of Surgical Oncology|November 13, 2013
Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Konstantinos I Votanopoulos, Reese W Randle, Brandon Craven, et al.
Journal of Surgical Oncology|January 6, 2015
Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapyReese W Randle, Shuja Ahmed, Edward A Levine, et al.
The Journal of Surgical Research|July 17, 2017
Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidismAndrew J Lowell, Norah M Bushman, Xing Wang, et al.
The Journal of Surgical Research|April 18, 2015
Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyReese W Randle, Kayla F Griffith, Nora F Fino, et al.
Pageof 7